Plakous Therapeutics Announces New Funding To Support Development Of Therapies For Necrotizing Enterocolitis
Plakous Therapeutics Announces New Funding To Support Development Of Therapies For Necrotizing Enterocolitis
07/05/22, 11:55 AM
Location
Plakous Therapeutics, Inc. today announced it is has received more than $300,000 in funding from the North Carolina Biotechnology Center (NCBiotech). The funding will support ongoing development and marketing of Protego-PDTM, the regenerative medicine company's first product.
Company Info
Location
winston-salem, north carolina, united states
Additional Info
Plakous Therapeutics is a biotherapeutic company dedicated to researching and developing placenta derived regenerative therapies to improve patient outcomes and reduce health care costs. For more information, please visit the company's website at plakoustherapeutics.com.
SOURCE Plakous Therapeutics, Inc.